• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远端胰腺切除术后新发糖尿病的危险因素。

Risk factors for new-onset diabetes mellitus after distal pancreatectomy.

机构信息

Department of General Surgery, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China

National Translational Medicine of China, Beijing, China.

出版信息

BMJ Open Diabetes Res Care. 2020 Oct;8(2). doi: 10.1136/bmjdrc-2020-001778.

DOI:10.1136/bmjdrc-2020-001778
PMID:33122295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7597507/
Abstract

INTRODUCTION

Several previous studies have reported the incidence of new-onset diabetes mellitus (NODM) after pancreatectomy. Nevertheless, the results were inconsistent. The true rate of NODM after distal pancreatectomy (DP) is still unknown.

RESEARCH DESIGN AND METHODS

The aim of this study was to investigate the incidence of and the risk factors for NODM after DP. This study enrolled patients who underwent DP between January 2004 and February 2016 at Peking Union Medical College Hospital. Patients with preoperative diabetes mellitus or diagnosed with pancreatic cancer were excluded. The primary outcome was NODM.

RESULTS

A total of 485 patients were enrolled. The median (IQR) of follow-up duration was 30.95 (9.26-180.30) months. The accumulative incidence of NODM was 8.9% at postoperative 6 months, 14.0% at postoperative year one, 22.3% at year three, 27.1% at year five, and 35.5% at year ten. Multivariate analysis showed that the risk of postoperative NODM was positively correlated with age (HR 1.029 (1.013-1.045), p<0.001), preoperative body mass index (BMI) (HR 1.042 (1.003-1.083), p=0.001), operative blood loss (HR 1.0003 (1.0002-1.0010), p<0.001), and length of resected pancreas (HR 1.079 (1.013-1.148), p0.017). Moreover, concomitant splenectomy (HR 2.001 (1.202-3.331), p=0.008) was associated with significantly higher risk of postoperative NODM.

CONCLUSION

NODM incidence increased with postoperative time progression. Age, BMI, surgical blood loss, length of resected pancreas and splenectomy were independent risk factors for NODM after DP.

TRIAL REGISTRATION NUMBER

NCT03030209.

摘要

介绍

几项先前的研究报告了胰腺切除术后新发糖尿病(NODM)的发生率。然而,结果并不一致。远端胰腺切除术(DP)后 NODM 的真实发生率仍不清楚。

研究设计与方法

本研究旨在探讨 DP 后 NODM 的发生率和危险因素。本研究纳入了 2004 年 1 月至 2016 年 2 月期间在北京协和医学院医院接受 DP 的患者。排除术前患有糖尿病或诊断为胰腺癌的患者。主要结局是 NODM。

结果

共纳入 485 例患者。中位(IQR)随访时间为 30.95(9.26-180.30)个月。术后 6 个月、1 年、3 年、5 年和 10 年的 NODM 累积发生率分别为 8.9%、14.0%、22.3%、27.1%和 35.5%。多因素分析显示,术后 NODM 的风险与年龄呈正相关(HR 1.029(1.013-1.045),p<0.001)、术前体重指数(BMI)(HR 1.042(1.003-1.083),p=0.001)、手术失血量(HR 1.0003(1.0002-1.0010),p<0.001)和切除胰腺的长度(HR 1.079(1.013-1.148),p=0.017)。此外,同时行脾切除术(HR 2.001(1.202-3.331),p=0.008)与术后 NODM 的高风险显著相关。

结论

NODM 的发生率随术后时间的延长而增加。年龄、BMI、手术失血量、切除胰腺的长度和脾切除术是 DP 后发生 NODM 的独立危险因素。

试验注册号

NCT03030209。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9539/7597507/4fc5c00c0724/bmjdrc-2020-001778f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9539/7597507/d72431ff7923/bmjdrc-2020-001778f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9539/7597507/4fc5c00c0724/bmjdrc-2020-001778f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9539/7597507/d72431ff7923/bmjdrc-2020-001778f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9539/7597507/4fc5c00c0724/bmjdrc-2020-001778f02.jpg

相似文献

1
Risk factors for new-onset diabetes mellitus after distal pancreatectomy.远端胰腺切除术后新发糖尿病的危险因素。
BMJ Open Diabetes Res Care. 2020 Oct;8(2). doi: 10.1136/bmjdrc-2020-001778.
2
Evaluation of allowable pancreatic resection rate depending on preoperative risk factors for new-onset diabetes mellitus after distal pancreatectomy.评估远端胰腺切除术后新发糖尿病的术前危险因素对允许胰腺切除率的影响。
Pancreatology. 2020 Oct;20(7):1526-1533. doi: 10.1016/j.pan.2020.08.005. Epub 2020 Aug 16.
3
New-Onset Diabetes Mellitus After Distal Pancreatectomy: A Systematic Review and Meta-Analysis.胰体尾切除术后新发糖尿病:一项系统评价与荟萃分析。
J Laparoendosc Adv Surg Tech A. 2020 Nov;30(11):1215-1222. doi: 10.1089/lap.2020.0090. Epub 2020 Jun 18.
4
New-onset diabetes after distal pancreatectomy: a systematic review.胰体尾切除术后新发糖尿病:一项系统评价
Ann Surg. 2015 May;261(5):854-61. doi: 10.1097/SLA.0000000000000819.
5
A novel clinical model for risk prediction and stratification of new-onset diabetes mellitus after distal pancreatectomy.一种用于预测远端胰腺切除术后新发糖尿病风险及分层的新型临床模型。
Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):868-881. doi: 10.21037/hbsn-22-382. Epub 2023 Mar 2.
6
Clinical utility of resected pancreatic volume ratio calculation for predicting postoperative new-onset diabetes mellitus after distal pancreatectomy-a propensity-matched analysis.切除胰腺体积比计算对预测远端胰腺切除术后新发糖尿病的临床效用——一项倾向匹配分析
Heliyon. 2023 May 3;9(5):e15998. doi: 10.1016/j.heliyon.2023.e15998. eCollection 2023 May.
7
Diabetes development after distal pancreatectomy: results of a 10 year series.远端胰腺切除术后糖尿病的发展:10 年系列研究结果。
HPB (Oxford). 2020 Jul;22(7):1034-1041. doi: 10.1016/j.hpb.2019.10.2440. Epub 2019 Nov 11.
8
Incidence and Risk Factors for New-Onset Diabetes Mellitus After Surgical Resection of Pancreatic Cystic Lesions: A MarketScan Study.胰腺囊性病变手术后新发糖尿病的发生率及危险因素:一项 MarketScan 研究。
Pancreas. 2022 May 1;51(5):427-434. doi: 10.1097/MPA.0000000000002054. Epub 2022 Jul 19.
9
Development of Postoperative Diabetes Mellitus in Patients Undergoing Distal Pancreatectomy Whipple Procedure.接受胰十二指肠切除术的远端胰腺切除患者术后糖尿病的发生情况
Am Surg. 2017 Oct 1;83(10):1050-1053.
10
Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors.胰体尾切除术后内分泌功能损害:发生率及相关因素
World J Surg. 2016 Feb;40(2):440-6. doi: 10.1007/s00268-015-3228-9.

引用本文的文献

1
Laparoscopic enucleation vs. pancreatectomy for small pancreatic neuroendocrine neoplasms: long-term functional and oncological outcomes.腹腔镜剜除术与胰腺切除术治疗小胰腺神经内分泌肿瘤:长期功能和肿瘤学结局
Surg Endosc. 2025 Aug 29. doi: 10.1007/s00464-025-11935-7.
2
Efficacy and safety of lateral approach laparoscopic spleen-preserving distal pancreatectomy: a multicenter retrospective cohort study.经侧方入路腹腔镜保留脾脏的远端胰腺切除术的疗效与安全性:一项多中心回顾性队列研究
Sci Rep. 2025 Aug 6;15(1):28799. doi: 10.1038/s41598-025-10997-w.
3
Significance of Pancreatic Steatosis as a Predictor of New-Onset Diabetes Mellitus Following Pancreatectomy.

本文引用的文献

1
Does the pancreatic volume reduction rate using serial computed tomographic volumetry predict new onset diabetes after pancreaticoduodenectomy?使用系列计算机断层扫描容积测量法得出的胰腺体积缩小率能否预测胰十二指肠切除术后新发糖尿病?
Medicine (Baltimore). 2017 Mar;96(13):e6491. doi: 10.1097/MD.0000000000006491.
2
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.国际研究小组(ISGPS)术后胰瘘定义与分级的2016年更新:11年后
Surgery. 2017 Mar;161(3):584-591. doi: 10.1016/j.surg.2016.11.014. Epub 2016 Dec 28.
3
Splenic preservation in laparoscopic distal pancreatectomy.
胰腺脂肪变性作为胰腺切除术后新发糖尿病预测指标的意义
Pancreas. 2025 Jul 18;54(9):e765-75. doi: 10.1097/MPA.0000000000002508.
4
Conceptualization of Remote Patient Monitoring Program for Patients with Complex Medical Illness on Hospital Dismissal.出院时针对患有复杂疾病患者的远程患者监测计划的概念化。
Mayo Clin Proc Digit Health. 2023 Oct 29;1(4):586-595. doi: 10.1016/j.mcpdig.2023.09.005. eCollection 2023 Dec.
5
The spleen assumes a major role in blood glucose regulation in type 1 diabetes patients treated with BCG.在接受卡介苗治疗的 1 型糖尿病患者中,脾脏在血糖调节中发挥主要作用。
Sci Rep. 2024 Jul 30;14(1):17611. doi: 10.1038/s41598-024-67905-x.
6
Relationship between pancreatic resection volume and post-operative glucose intolerance in distal pancreatectomy: A retrospective study.远端胰腺切除术中胰腺切除体积与术后葡萄糖不耐受的关系:一项回顾性研究。
Indian J Gastroenterol. 2024 Jul 16. doi: 10.1007/s12664-024-01592-4.
7
Association Between Hypotension During Pancreatectomy and Development of Postoperative Diabetes.胰十二指肠切除术中低血压与术后糖尿病发生之间的关联
J Clin Endocrinol Metab. 2025 Jan 21;110(2):e249-e256. doi: 10.1210/clinem/dgae227.
8
Quantitative Metabolomics and Lipoprotein Analysis of PDAC Patients Suggests Serum Marker Categories for Pancreatic Function, Pancreatectomy, Cancer Metabolism, and Systemic Disturbances.PDAC 患者的定量代谢组学和脂蛋白分析提示了与胰腺功能、胰腺切除术、癌症代谢和全身紊乱相关的血清标志物类别。
J Proteome Res. 2024 Apr 5;23(4):1249-1262. doi: 10.1021/acs.jproteome.3c00611. Epub 2024 Feb 26.
9
High Incidence of Diabetes Mellitus After Distal Pancreatectomy and Its Predictors: A Long-term Follow-up Study.胰体尾切除术后糖尿病的高发病率及其预测因素:一项长期随访研究
J Clin Endocrinol Metab. 2024 Feb 20;109(3):619-630. doi: 10.1210/clinem/dgad634.
10
The Effect of Body Mass Index on Patients' Outcomes Following Robotic Distal Pancreatectomy and Splenectomy.体重指数对机器人远端胰腺切除术和脾切除术患者结局的影响。
JSLS. 2023 Apr-Jun;27(2). doi: 10.4293/JSLS.2022.00046.
腹腔镜胰体尾切除术保脾。
Br J Surg. 2017 Mar;104(4):452-462. doi: 10.1002/bjs.10434. Epub 2016 Dec 22.
4
Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection.胰腺切除术后30天的结果低估了内分泌和外分泌功能不全的情况。
HPB (Oxford). 2016 Apr;18(4):360-6. doi: 10.1016/j.hpb.2015.11.003. Epub 2016 Feb 17.
5
New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.新发2型糖尿病、糖化血红蛋白升高、抗糖尿病药物与胰腺癌风险
Br J Cancer. 2015 Dec 1;113(11):1607-14. doi: 10.1038/bjc.2015.353. Epub 2015 Nov 17.
6
Factors Affecting the Development of Diabetes Mellitus After Pancreatic Resection.胰腺切除术后影响糖尿病发生发展的因素
Pancreas. 2015 Nov;44(8):1296-303. doi: 10.1097/MPA.0000000000000404.
7
Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors.胰体尾切除术后内分泌功能损害:发生率及相关因素
World J Surg. 2016 Feb;40(2):440-6. doi: 10.1007/s00268-015-3228-9.
8
Incidence and severity of pancreatogenic diabetes after pancreatic resection.胰腺切除术后胰源性糖尿病的发病率和严重程度。
J Gastrointest Surg. 2015 Feb;19(2):217-25. doi: 10.1007/s11605-014-2669-z. Epub 2014 Oct 15.
9
Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance.脾脏在白色脂肪组织中维持着一群固有样B细胞,这些细胞可预防与肥胖相关的胰岛素抵抗。
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4638-47. doi: 10.1073/pnas.1324052111. Epub 2014 Oct 13.
10
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.糖尿病、抗糖尿病药物与胰腺癌风险:来自国际胰腺癌病例对照研究联盟的分析
Ann Oncol. 2014 Oct;25(10):2065-2072. doi: 10.1093/annonc/mdu276. Epub 2014 Jul 23.